Qiagen NV. (QGEN) NEW YORK STOCK EXCHANGE INC.
$41.52 (0.37) (-0.88%)
Market Cap: $9.47B
As of 04/24/24 04:00 PM EDT. Market closed.
Qiagen NV. (QGEN)
NEW YORK STOCK EXCHANGE INC.
$41.52
(0.37) (-0.88%)
Market Cap: $9.47B
As of 04/24/24 04:00 PM EDT. Market closed.
qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights. qiagen sample technologies isolate and process dna, rna and proteins from blood, tissue and other materials. assay technologies make these biomolecules visible and ready for analysis. bioinformatics software and knowledge bases interpret data to report relevant, ... read more
qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights. qiagen sample technologies isolate and process dna, rna and proteins from blood, tissue and other materials. assay technologies make these biomolecules visible and ready for analysis. bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. automation solutions tie these together in seamless and cost-effective molecular testing workflows. qiagen provides these workflows to more than 500,000 customers around the world in molecular diagnostics (human healthcare), applied testing (forensics, veterinary testing and food safety), pharma (pharmaceutical and biotechnology companies) and academia (life sciences research). as of june 30, 2015, qiagen employed approximately 4,400 people in over 35 locations worldwide. further information can be found at http://www.qiagen.com. read less
COMPANY PROFILE
CEO
Thierry Bernard
Full Time Employees
5,070
URL
Address
Hulsterweg 82, Limburg, Venlo, 5912 PL.
Address
Hulsterweg 82, Limburg, Venlo, 5912 PL.
PRICE CHART FOR QIAGEN NV
KEY STATS
Open
$41.75
Previous Close
$41.89
Days Range
$41.25 - $41.82
52 week range
$34.77 - $47.75
Volume
816,213
Avg. Volume (30 days)
912,520
Market Cap
$9.47B
Dividend Yield
-
P/E
27.76
Shares Outstanding
228,202,755
Days Range
$41.25 - $41.82
52 week range
$34.77 - $47.75
Avg. Volume (30 days)
912,520
Shares Outstanding
228,202,755
FINANCIAL STATEMENTS FOR QIAGEN NV
LOADING...
FUNDS WITH A POSITION IN QIAGEN NV
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|
BLACKROCK INC. | 7,858,440 | 0.0087% | 4.89% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,071,890 | 0.00487% | 3.29% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 362,098 | 0.03% | -66.07% | Event Driven |
D. E. SHAW & CO., INC. | 229,449 | 0.00871% | -25.45% | Other |
TUDOR INVESTMENT CORP ET AL | 124,382 | 0.04% | New | Event Driven, Other |
AQR CAPITAL MANAGEMENT LLC | 121,784 | 0.00996% | -40.04% | Other |
MAGNETAR FINANCIAL LLC | 30,375 | 0.03% | 165.82% | Event Driven, Other |
GABELLI FUNDS LLC | 26,500 | 0.00886% | No change | Event Driven, Growth, Activists |
GOTHAM ASSET MANAGEMENT, LLC | 11,202 | 0.00903% | -22.86% | Other |
CHANGE IN SHARES OUTSTANDING FOR QIAGEN NV
STOCK BUYBACKS FOR QIAGEN NV
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.06%
1Q
12/31/2023
06/30/2023
0.10%
2Q
12/31/2023
03/31/2023
0.06%
3Q
12/31/2023
12/31/2022
0.17%
4Q
12/31/2023
09/30/2022
0.29%
5Q
12/31/2023
06/30/2022
0.35%
6Q
12/31/2023
03/31/2022
0.25%
7Q
12/31/2023
12/31/2021
-0.44%
8Q
12/31/2023
09/30/2021
-0.60%
9Q
12/31/2023
06/30/2021
-0.52%
10Q
12/31/2023
03/31/2021
-0.67%
11Q
12/31/2023
12/31/2020
-1.74%
12Q
12/31/2023
09/30/2020
-1.39%
13Q
12/31/2023
06/30/2020
-1.40%
14Q
12/31/2023
03/31/2020
-0.63%
15Q
12/31/2023
12/31/2019
1.75%
16Q
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
Load More
BUYBACK ANNOUNCEMENT(S) FOR QIAGEN NV
LOADING...